# Flupenthixol Decanoate in Methamphetamine Smoking - 1

> **NCT00000241** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 58 (—)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** Flupenthixol

## Key facts

- **NCT ID:** NCT00000241
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-02
- **Primary completion:** —
- **Final completion:** 1996-05
- **Target enrollment:** 58 (—)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000241, "Flupenthixol Decanoate in Methamphetamine Smoking - 1". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*